Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
38.65
-0.52 (-1.33%)
After Hours: 38.65 0.00 (0.00%)
Feb 11, 4:35PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 37.78 - 39.93
52 week 37.71 - 66.89
Open 38.69
Vol / Avg. 328,373.00/262,999.00
Mkt cap 860.61M
P/E 33.27
Div/yield 0.11/1.14
EPS 1.16
Shares 22.64M
Beta 0.88
Inst. own 103%
Apr 28, 2016
Q4 2016 Abaxis Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jan 28, 2016
Q3 2016 Abaxis Inc Earnings Call
Jan 28, 2016
Q3 2016 Abaxis Inc Earnings Release
Jan 14, 2016
Abaxis Inc at JPMorgan Healthcare Conference
Dec 16, 2015
Abaxis Inc at Bank of America Merrill Lynch Animal Health Summit
Dec 1, 2015
Abaxis Inc at Piper Jaffray Healthcare Conference
Nov 19, 2015
Abaxis Inc at Jefferies Autumn Global Healthcare Conference
Nov 19, 2015
Abaxis Inc at Canaccord Genuity Medical Technology & Diagnostics Forum
Nov 17, 2015
Abaxis Inc at Stifel Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 15.04% 10.27%
Operating margin 21.29% 16.93%
EBITD margin - 21.12%
Return on average assets 11.78% 8.55%
Return on average equity 13.50% 10.05%
Employees 582 -
CDP Score - -

Address

3240 Whipple Rd
UNION CITY, CA 94587-1217
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company operates through the two segments: the medical market and the veterinary market. The Company's medical market customer group consists of physicians' office practices across multiple specialties, urgent care, outpatient and walk-in clinics, health screening operations, home care providers and nursing homes. The Company's medical market products include: Piccolo chemistry analyzers and consumable products. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Officers and directors

Clinton H. Severson Chairman of the Board, Chief Executive Officer
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald Peter Wood President, Chief Operating Officer
Age: 63
Bio & Compensation  - Reuters
Ross Taylor Chief Financial Officer, Vice President - Finance, Secretary
Age: 52
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 62
Bio & Compensation  - Reuters
Craig M. Tockman Vice President - Animal Health Sales and Marketing for North America
Age: 55
Bio & Compensation  - Reuters
Achim Henkel Managing Director of Abaxis Europe GmbH
Age: 57
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 69
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 72
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 69
Bio & Compensation  - Reuters
Henk J. Evenhuis Independent Director
Age: 72
Bio & Compensation  - Reuters